196 related articles for article (PubMed ID: 23660976)
1. Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity.
Sridevi P; Nhiayi MK; Wang JY
Cell Death Differ; 2013 Jul; 20(7):953-62. PubMed ID: 23660976
[TBL] [Abstract][Full Text] [Related]
2. Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.
Kim SY; Cordeiro MH; Serna VA; Ebbert K; Butler LM; Sinha S; Mills AA; Woodruff TK; Kurita T
Cell Death Differ; 2013 Aug; 20(8):987-97. PubMed ID: 23598363
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity.
Skorta I; Oren M; Markwardt C; Gutekunst M; Aulitzky WE; van der Kuip H
Cancer Res; 2009 Dec; 69(24):9337-45. PubMed ID: 19934315
[TBL] [Abstract][Full Text] [Related]
4. Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals.
Preyer M; Shu CW; Wang JY
Cell Death Differ; 2007 Jun; 14(6):1139-48. PubMed ID: 17363963
[TBL] [Abstract][Full Text] [Related]
5. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
6. c-Abl mediates angiotensin II-induced apoptosis in podocytes.
Chen X; Ren Z; Liang W; Zha D; Liu Y; Chen C; Singhal PC; Ding G
J Mol Histol; 2013 Oct; 44(5):597-608. PubMed ID: 23515840
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury.
Gordon M; El-Kalla M; Zhao Y; Fiteih Y; Law J; Volodko N; Anwar-Mohamed A; El-Kadi AO; Liu L; Odenbach J; Thiesen A; Onyskiw C; Ghazaleh HA; Park J; Lee SB; Yu VC; Fernandez-Patron C; Alexander RT; Wine E; Baksh S
PLoS One; 2013; 8(10):e75483. PubMed ID: 24146755
[TBL] [Abstract][Full Text] [Related]
8. Autophagy in proximal tubules protects against acute kidney injury.
Jiang M; Wei Q; Dong G; Komatsu M; Su Y; Dong Z
Kidney Int; 2012 Dec; 82(12):1271-83. PubMed ID: 22854643
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone.
Alpay K; Farshchian M; Tuomela J; Sandholm J; Aittokallio K; Siljamäki E; Kallio M; Kähäri VM; Hietanen S
PLoS One; 2014; 9(8):e105526. PubMed ID: 25148385
[TBL] [Abstract][Full Text] [Related]
10. Role of Abl in airway hyperresponsiveness and airway remodeling.
Cleary RA; Wang R; Wang T; Tang DD
Respir Res; 2013 Oct; 14(1):105. PubMed ID: 24112389
[TBL] [Abstract][Full Text] [Related]
11. Lethal (3) malignant brain tumor-like 2 (L3MBTL2) protein protects against kidney injury by inhibiting the DNA damage-p53-apoptosis pathway in renal tubular cells.
Huang H; Xu C; Wang Y; Meng C; Liu W; Zhao Y; Huang XR; You W; Feng B; Zheng ZH; Huang Y; Lan HY; Qin J; Xia Y
Kidney Int; 2018 Apr; 93(4):855-870. PubMed ID: 29276099
[TBL] [Abstract][Full Text] [Related]
12. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
Dicker F; Kater AP; Prada CE; Fukuda T; Castro JE; Sun G; Wang JY; Kipps TJ
Blood; 2006 Nov; 108(10):3450-7. PubMed ID: 16741250
[TBL] [Abstract][Full Text] [Related]
13. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.
Jiang M; Wei Q; Wang J; Du Q; Yu J; Zhang L; Dong Z
Oncogene; 2006 Jul; 25(29):4056-66. PubMed ID: 16491117
[TBL] [Abstract][Full Text] [Related]
14. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.
Huang DY; Chao Y; Tai MH; Yu YH; Lin WW
J Biomed Sci; 2012 Mar; 19(1):35. PubMed ID: 22462553
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.
Youlyouz-Marfak I; Gachard N; Le Clorennec C; Najjar I; Baran-Marszak F; Reminieras L; May E; Bornkamm GW; Fagard R; Feuillard J
Cell Death Differ; 2008 Feb; 15(2):376-85. PubMed ID: 17992189
[TBL] [Abstract][Full Text] [Related]
16. Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL.
Preyer M; Vigneri P; Wang JY
PLoS One; 2011 Feb; 6(2):e17020. PubMed ID: 21347248
[TBL] [Abstract][Full Text] [Related]
17. Abl family kinases regulate endothelial barrier function in vitro and in mice.
Chislock EM; Pendergast AM
PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707
[TBL] [Abstract][Full Text] [Related]
18. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
[TBL] [Abstract][Full Text] [Related]
19. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
20. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
